Tag:

vacuna

Health

Zamora Nears 50,000 Flu Vaccine Doses Amid Surge in Infections

by Chief Editor
written by Chief Editor

Castilla y León surpasses 650,000 Flu Vaccine Doses; 9,269 RSV Inoculations for Children

In a concerted effort to safeguard public health, the regional government of Castilla y León has administered a total of 651,391 influenza vaccine doses, with Valladolid taking the lead in provincial distribution. This significant milestone in the region’s immunization drive underscores the commitment to prevent the spread of seasonal flu.

Valladolid heads the list with 141,786 doses administered, closely followed by León with 116,127, and Salamanca with 92,254. The province of Zamora has seen 50,562 vaccinations thus far.

Moreover, the autonomous community maintains an active campaign to protect against the Respiratory Syncytial Virus (RSV), which can cause serious diseases like bronchiolitis and pneumonia in children. With 9,269 doses of the monoclonal antibody nirsevimab administered, the region has achieved a 67.7% coverage rate against the initial 13,700 doses procured.

This RSV immunization initiative targets children born between April 2024 and March 2025, as well as those with underlying health conditions who require a second dose in their second year of life. Once again, Valladolid leads in inoculations with 2,255 doses, trailed by Burgos (1,463) and León (1,448). Zamora has administered 491 doses.

Among the various target groups, those at risk due to age have received the highest number of vaccinations, totaling 303,417 doses. Individuals in institutional care follow with 39,768 doses, and those with pre-existing conditions come in third with 34,149 doses. Additionally, 7,251 healthcare professionals and 6,469 workers in the socio-sanitary sector have been vaccinated.

0 comments
0 FacebookTwitterPinterestEmail
Health

Santiago Tops Chile in Vaccinating Seniors Against Influenza

by Chief Editor
written by Chief Editor

Galicia‘s Anti-Grippe Vaccination Campaign Exceeds Expectations in Santiago and Barbanza

As the cold winter of 2025 sets in, the healthcare system in Galicia braces for the upcoming flu season. However, the region has reason to be optimistic, thanks to the successful progress of the anti-grippe vaccination campaign in the Santiago and Barbanza area.

Leading the Pack

The vaccination drive, targeting both the elderly and young children, has seen remarkable success. As of mid-December, the area leads the region in vaccination coverage for both seniors over 65 and children between 6 and 59 months. Theumps figure stands at 70.79% for seniors, with 81,355 out of 114,920 eligible citizens vaccinated. For children, the coverage is 69.43%, with 8,170 out of 11,768 children immunized.

Center-by-Center Performance

Breaking down the numbers, the Vite Healthcare Center in Santiago leads the pack with a 74.77% vaccination rate, while the Vedra Center boasts the highest rate among all centers at 76.84%. Meanwhile, the Rianxo Center has the lowest rate, at 60.59%.

Introducing the Intranasal Vaccine

This year marks the first time the intranasal vaccine has been administered to children aged 2 to 5. The goal was to increase coverage from 56% to 60%, a target that the Santiago area has already surpassed. The campaign continues until January 18, with the aim of further boosting vaccination rates.

Vaccination Rates Among the Elderly

The vaccination drive among seniors over 65 has seen mixed results. Those aged 80 to 84 have the highest vaccination rate at 78.86%, followed closely by those over 85, at 78.01%. The rate drops significantly for those aged 60 to 64, with only 41.22% vaccinated.

While these figures are encouraging, there is still work to be done to ensure that as many people as possible are protected against the flu this winter. With the campaign continuing until mid-January, there is still time to get vaccinated and contribute to the overall effort to keep Galicia healthy.

0 comments
0 FacebookTwitterPinterestEmail
Health

Minsal Weighs Mandatory COVID Vaccine for 2025

by Chief Editor
written by Chief Editor

Title: Chile Considers Permanent COVID-19 Vaccination as Experts Recommend Integration into National Immunization Program

Five years ago, on December 31, 2019, a resident of Wuhan, China, was hospitalized with symptoms that didn’t match any known disease. This patient would become the first diagnosed with COVID-19, an infectious disease that sparked a global health crisis and was later partially controlled through mass vaccination. Chile was not immune to this global challenge.

On December 24, 2020, at 11:41 AM, Chile administered its first COVID-19 vaccine in Santiago, marking the beginning of a mass immunization campaign that has since provided over 70 million doses, including basic and booster schemes.

Now, with the coronavirus no longer the threat it once was, Chile’s epidemiological situation has evolved, leading to changes in public health strategies. In response, the Ministry of Health (Minsal) requested the Committee of Vaccines and Immunization Strategies (Cavei) to evaluate the implementation of the COVID-19 vaccine in the national immunization program starting from 2025.

After weeks of debate, the expert group recommended incorporating the COVID-19 vaccination into the Decree No. 50/2021, making it mandatory for specific groups to prevent morbidity and mortality, especially in high-risk individuals, and to preserve the integrity and capacity of the healthcare system.

This recommendation suggests that COVID-19 vaccination could become a permanent public health measure in Chile, similar to other vaccinations like influenza or measles, for specific groups.

The Cavei suggested that the same objective groups currently eligible for the vaccine would be the candidates for this strategy. Currently, the vaccine is available for those aged 60 and above, immunocompromised patients, healthcare professionals, individuals with chronic diseases, and pregnant women, provided they have completed one year since their last dose.

The expert group also recommended administering the COVID-19 and influenza vaccines simultaneously in eligible population groups to optimize vaccination opportunities and administrative logistics.

The final decision now lies with the Minsal, which is currently evaluating the Cavei’s recommendation. Meanwhile, the vaccine remains available for eligible groups at public or private vaccination centers in agreement with each regional health service.

According to the ministry’s latest report, 14 people died from the disease last week. Experts have repeatedly emphasized that vaccination has been one of the most effective measures to combat the disease.

A study by researchers from the Center for Mathematical Modeling (CMM) and Dr. Mauricio Canals from the School of Public Health at the University of Chile found that the vaccination campaign in Chile significantly mitigated the disease. The study estimated that during the 2021 and 2022 campaigns, the vaccine prevented 1,030,648 infections, 268,784 hospitalizations, 85,830 ICU admissions, and 75,968 COVID-19-related deaths in individuals aged 16 and above.

0 comments
0 FacebookTwitterPinterestEmail
Health

**"Paraguay Considers Dengue Vaccination Campaign in Coming Months"

by Chief Editor
written by Chief Editor

Headline: Paraguay: Dengue Vaccination Set for 2025; Ministry Studies Target Population

Article:

Paraguay’s Health Ministry is gearing up to introduce the dengue vaccine in 2025, with the first doses expected to arrive in the coming months. The directive, revealed by Dr. Andrea Ojeda, Director of Health Surveillance, comes as Brazil and Argentina have kicked off their vaccination campaigns. Paraguay’s Ministry of Health is currently conducting field studies to determine which sector of the population will receive the vaccine initially.

Dr. Ojeda, speaking with "Dos en la Ciudad" on channel Gen and Universo 970/Nación Media, highlighted that introducing the dengue vaccine is among the ministry’s planned strategies for the near future. She emphasized that deciding on the target population involves meticulous analysis of factors like age group and the optimal vaccination period.

The director also noted that dengue cases are being closely monitored across the country. As of now, there are over 900 suspected cases being investigated, with 110 confirmed cases spread across 15 sanitary regions. Alto Paraguay and Concepción have reported the highest number of confirmed cases.

In other vaccination news, the country has seen a high coverage rate for the Human Papillomavirus (HPV) vaccine, with the inclusion of males in the vaccination program commended by health authorities.

0 comments
0 FacebookTwitterPinterestEmail
Health

2025 Vacations: Essential Vaccinations for International Travel

by Chief Editor
written by Chief Editor

Title: Ensuring Safe Travels: Essential Vaccinations for International Journeys

SEO Keywords: Travel vaccinations, safe travel, international travel, vacation health, medical tourism

Meta Description: Discover which vaccinations are essential for international travel, from Brazil‘s yellow fever requirement to the protection against diseases like dengue and hepatitis. Plan your trip safely with expert advice.

Article:

When planning an international vacation, selecting destinations and booking accommodations are vital steps. However, it’s also crucial to consider your health and the potential risks associated with traveling to new regions. Vaccinations play a significant role in preventing diseases that may be prevalent in your destination country.

Yellow Fever: A Global Requirement

One of the most commonly required vaccinations is against yellow fever, a serious viral infection typically found in tropical and subtropical areas in South America and Africa. Many countries, including those in the Americas, require proof of vaccination against yellow fever for entry. Even Brazil, which previously did not demand it for visitors, now recommends vaccination for traveling to certain areas within the country, such as popular tourist destinations like Rio de Janeiro, Florianópolis, and Búzios.

Fun Fact: The yellow fever vaccine is valid for 10 years for adults and throughout life for those vaccinated at or after 9 months of age. However, the World Health Organization (WHO) recommends booster doses for some individuals, such as those traveling to high-risk areas or working in healthcare settings.

Other Recommended Vaccines

While not always required, several vaccinations are highly recommended to protect your health during international trips:

  1. Hepatitis B – Síntomas y causas – Mayo Clinic”>Hepatitis A and B: These vaccines are ideal for visits to regions with poor sanitary conditions, as hepatitis is a common issue in these areas.
  2. Typhoid fever: Recommended for destinations where clean drinking water might not be available or easy to access.
  3. Dengue fever: Especially important when visiting tropical regions where the Aedes Aegypti mosquito is prevalent. A vaccine is available for individuals aged 9-45 who have been previously infected with dengue or live in or are traveling to areas where dengue is present.

Consult a Travel Health Expert

To ensure you receive the necessary vaccinations and stay safe during your travels, consult a medical professional specializing in travel health. They can assess your health status, determine which vaccinations are required or recommended for your specific destination, and provide personalized advice to minimize your risk of illness or infection.

Pro Tip: Schedule your appointment at least four to six weeks before your trip, as some vaccinations require multiple doses or take time to become fully effective.

Enjoy your international adventures with peace of mind, knowing that you’ve taken the necessary steps to protect your health. Safe travels!

Internal Links:

Yellow Fever Vaccine: What Travelers Need to Know

Traveling to Brazil: What Vaccines Do You Need?

External Links:

World Health Organization – International Travel and Health

CDC Travelers’ Health – Vaccines and Medications

0 comments
0 FacebookTwitterPinterestEmail
Health

Worker Claims Against AstraZeneca: Lobbying for Recognizing Job-Related Origins of Vaccine-Induced Thrombosis

by Chief Editor
written by Chief Editor

"AstraZeneca Vaccine Aftermath: Patients Seeking Justice and Recognition"

While the COVID-19 pandemic continues, a silent health crisis unfolds for a small group of individuals who received the AstraZeneca vaccine. These patients, whose voices have largely been unheard, are now seeking justice and recognition, alleging adverse effects from the vaccine that was eventually withdrawn by the manufacturer due to rare cases of blood clots.

A Silent Struggle

Pedro García, a 50-year-old physics and chemistry teacher from Barcelona, is one such individual. He received the AstraZeneca vaccine as a frontline worker on February 24, 2021. Days later, he was rushed to the Hospital del Mar in Barcelona with severe symptoms. Medical scans revealed blood clots in his lung and liver, leading to an emergency surgery and a week-long stay in the intensive care unit. García is now a member of the Asociación de Trabajadores Esenciales Afectados por la Vacuna de AstraZeneca (Ateava), a group of 135 individuals seeking recognition and compensation for their health issues.

Reclaiming Contingency

Ateava members assert that their health problems are directly linked to their vaccination as essential workers. They seek official recognition of ‘contingency labor’ and adequate compensation. Their cases may soon gain traction, with the first judgments set to take place in Spain in 2025. García’s trial is scheduled for March in Barcelona.

A Complex Issue

Medical experts agree that while the AstraZeneca vaccine can cause blood clots in rare cases, the overall risk is low. They maintain that the benefits of vaccination still outweigh the risks. However, Pedro García’s ordeal showcases the human face of these ‘rare’ cases. Moreover, the true extent of AstraZeneca-related health issues remains unclear, with many affected individuals left without support or recognition.

A Call for Further Investigation

With the pandemic still ongoing and potential future health crises looming, affected individuals and healthcare professionals alike call for more thorough investigations into the long-term effects of the AstraZeneca vaccine. They demand greater transparency and accountability from pharmaceutical companies and governments, as well as adequate compensation for those adversely impacted.

Challenging Medical Narratives

Some affected individuals, like Leticia Bravo, a 53-year-old teacher from Málaga, challenge the typical narrative of vaccine-related illnesses. Though she did not develop blood clots, Bravo was diagnosed with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) following her AstraZeneca vaccination. Despite her condition, she emphasizes that her stance is not antivaccine, but rather pro-transparency and accountability. "We’re not antivaccine at all," she asserts. "We did what we believed was best at the moment. But now, we want those who pushed us to take that step to assume responsibility."

0 comments
0 FacebookTwitterPinterestEmail
Health

Pre-Birth Protection: The Vaccine That Shields Before Birth

by Chief Editor
written by Chief Editor

La Vacunación contra la Tosferina en el Embarazo, una Medida éclair de Salubridad Pública en La Rioja

La primera vacuna de la vida de los nuevos riojanos llega incluso antes de nacer. Entre la semana 27 y 36 de gestación, las embarazadas reciben una dosis contra la tosferina que funciona como protección doble, para ellas y para los pequeños. Esta medida de salubridad pública se lleva a cabo desde hace casi una década y cuenta con alta aceptación, con un 98% de las embarazadas riojanas vacunadas este año, lo que resulta crucial para reducir la gravedad y la incidencia de esta enfermedad.

La tosferina es una enfermedad bacteriana que puede causar infecciones respiratorias graves en los primeros meses de vida, requiriendo incluso hospitalización. Tradicionalmente, la vacuna contra la tosferina se administraba por primera vez a los dos meses de vida del niño. Sin embargo, desde 2015, se empezó a vacunar a las embarazadas entre las semanas 27 y 36 de gestación, creando una doble protección para madre e hijo.

Esta vacunación en el embarazo ha demostrado ser sumamente efectiva, ya que las defensas pasan a través de la placenta y protegen al niño hasta que recibe su primera vacuna. Además, vacunar a las madres incrementa las defensas maternas y el paso de anticuerpos a través de la placenta al feto.

La directora general de Salud Pública de La Rioja, Eva Martínez Ochoa, señala que el objetivo es proteger a bebés no vacunables, menor de dos meses, los cuales sufren la enfermedad de forma grave y no pueden ser vacunados antes de alcanzar esa edad. Esta estrategia ha sido muy exitosa, manteniendo las coberturas de vacunación siempre por encima del 95%, una cifra que supera la media nacional.

"Empezó a recomendarse por un aumento de casos de tosferina en lactantes en las primeras semanas de vida. Son niños que sufren la enfermedad de forma grave y no se les puede vacunar antes de los dos meses, por lo que se vio que vacunando a las madres se produce un paso de anticuerpos a través de la placenta para proteger al bebé", comenta Martínez Ochoa.

Sin embargo, este año se ha registrado un importante aumento en la incidencia de la tosferina, con 59 casos hasta comienzos de diciembre, comparado con los 13 registrados en 2023 y solo uno en los dos años anteriores. A pesar de este repunte, el impacto en lactantes está siendo bajo, lo que indica que la estrategia de vacunación está teniendo el efecto deseado.

Organismos como la Asociación Española de Pediatría han destacado la importancia de esta medida, mientras que estudios del Instituto de Salud Carlos III han mostrado una reducción a la mitad de la hospitalización de lactantes menores de dos meses tras la inclusión de la vacuna en el embarazo.

La vacunación contra la tosferina en el embarazo se ha convertir en una medida éclair de salubridad pública en La Rioja, y su importancia se hace aún más relevante en un contexto de repunte de casos. Esta medida protector

0 comments
0 FacebookTwitterPinterestEmail
Health

Tucumán Launches Targeted Dengue Vaccination Campaign for At-Risk Groups and Individuals Aged 10-49

by Chief Editor
written by Chief Editor

Breaking News: Chile Expands Vaccination Drive to Protect More Adults and Key Workers Against Dengue

In a significant boost to its nationwide vaccination campaign against dengue fever, Chile has announced an expansion that targets a broader range of adults and essential workers. The move, spearheaded by Health Minister Enrique Paris, aims to shield more individuals and reinforce the country’s immunity against the mosquito-borne disease.

According to the latest decrees, the vaccination drive will now prioritize personnel from the healthcare, education, and security sectors, as well as federal forces—those on the frontlines battling the pandemic and maintaining essential services. Additionally, all individuals aged between 10 and 49 are eligible to receive the jab, providing them with an opportunity to complete their vaccination calendars.

Minister Paris emphasized, "We want to ensure that all individuals have access to protection against this potentially severe illness. By vaccinating a broader age range and key workers, we can jointly combat dengue while continuing to safeguard our communities’ well-being."

For those who have already received their first dose, the wait for the second is over. Authorities have confirmed that individuals who received their initial vaccination three months ago can now access their second dose, further strengthening their immunity and RBC response against dengue.

The expanded vaccination drive comes as part of Chile’s continued commitment to tackling dengue, with the ministry reminding the public to remain vigilant against mosquito breeding sites and to consult with healthcare professionals for personalized advice and guidance.

Stay informed and stay safe. For more information on the vaccination process and to find nearby vaccination centers, visit the Ministry of Health’s official website.

0 comments
0 FacebookTwitterPinterestEmail
Health

Influenza Surge in Navarra: 19 Hospitalizations in a Week

by Chief Editor
written by Chief Editor

Rise in Respiratory Infections: Grippe, Covid, and Pneumonia Cases in Navarra

The aggravating situation of respiratory infections in Navarra continues, with a staggering 744 cases per 100,000 inhabitants reported by the Instituto de Salud Pública y Laboral de Navarra in its epidemiological report for the week of December 16-22. Out of these, 79 were cases of influenza-like syndrome, 4 were COVID-19, and 11 were pneumonia, highlighting the urgent need for public health intervention.

Grippes cases have surged, with 63 positive cases reported, up from the previous week’s 46. Worse yet, 19 individuals required hospitalization, nearly doubling the 9 hospitalizations reported the week prior. The region is also grappling with a medium-level circulation of the respiratory syncytial virus (RSV), with 41 confirmed cases, 25 of which resulted in hospitalization, including 9 pediatric cases. COVID-19, still pertinent, has resulted in five cases, with three requiring hospitalization.

Since its inception on October 14, the co-administration of influenza and COVID-19 vaccines has been encouraging, with 152,692 and 100,764 doses administered, respectively. Nevertheless, public health officials stress the importance of additional preventive measures. These include vaccination for vulnerable populations, maintaining interpersonal distance, mask-wearing, and adequate ventilation to mitigate severe infections.

Newborns and lactating infants are particularly vulnerable to severe respiratory infections. To protect them, health authorities advise frequent handwashing, cleaning objects they come into contact with, minimizing close contact with individuals presenting respiratory symptoms, and avoiding exposure to tobacco smoke. Furthermore, individuals with symptoms of acute respiratory infections should refrain from visiting or caring for young children.

The Region’s health department emphasizes the protective role of breastfeeding against RSV infections and underscores the importance of maintaining vaccination uptake, mask-wearing, and social distancing to combat the ongoing respiratory virus threat.

0 comments
0 FacebookTwitterPinterestEmail
Health

Flu Vaccine: No appointment needed for children aged 6 to 59 months this Thursday

by Chief Editor
written by Chief Editor

Special Vaccination Drive: Andalusia‘s Health Department to Vaccinate Children Against the Flu Without Appointment

Andalusia’s Health Department has announced a special vaccination drive for children aged between 6 and 59 months who have not yet been vaccinated against the flu. This initiative will take place on Thursday, December 26, without the need for an appointment, across all provinces in Andalusia, including Almería.

The Andalusian Health Service (SAS) has set up more than 350 vaccination points throughout the region. A comprehensive list of these points, including their locations and operating hours, is available on the website https://lajunta.es/59f9p.

In the province of Almería, vaccinations will be administered at health centers in 32 municipalities. Most of these centers will operate until 2:30 PM. The complete list of municipalities and their respective vaccination points includes Almería capital, Alhama de Almería, Abrucena, Abla, Vícar, Roquetas de mar, Laujar de Andarax, Fondón, El Ejido, Dalías, Berja, Balanegra, Alcolea, Adra, Benahadux, Gádor, Gérgal, Huércal de Almería, Nacimiento, Níjar, Pechina, Sorbas, Tabernas, Viator, Albox, Cuevas del Almanzora, Garrucha, Huércal Overa, Mojácar, Pulpí, Serón, Vera, and Vélez Rubio.

The objective of this campaign is to vaccinate children who have not received the flu shot yet, aiming to protect them from potential severe cases and complications. As per the analysis of recent data, the peak of respiratory virus infections is expected to occur in January, making it crucial to immunize vulnerable populations before then.

The current vaccination campaign for children began on September 30, and nearly 155,265 children, representing 56.6% of the target population, have already been vaccinated. The vaccination rate is even higher for children aged between 36 and 59 months, with 63.7% of this age group receiving the vaccination at their schools.

Furthermore, the vaccination campaign against the Respiratory Syncytial Virus (RSV), which causes broncholitis in infants, began on September 23. So far, 95% of infants born since April 1, 2024, equivalent to 40,148 babies, have been vaccinated. This vaccine is also administered to infants with a history of premature birth or other high-risk conditions up to 24 months old.

Don’t miss this opportunity to protect your child against the flu and other respiratory illnesses. Visit the nearest vaccination point in your municipality to ensure your little one receives the necessary care in time.

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts